The Supreme Court temporarily restored broad access to the abortion pill mifepristone, blocking a ruling that would have severely restricted its availability nationwide and impacting the primary method of abortion in the U.S.
The Supreme Court on Monday temporarily restored widespread access to the abortion pill mifepristone, halting a lower court's decision that threatened to significantly limit its availability across the United States. This move is crucial as medication abortion, typically involving mifepristone and a second drug, misoprostol, accounts for the majority of abortions in the U.S. Its availability has been key in countering abortion bans enacted by many Republican-led states following the 2022 overturning of Roe v. Wade. The legal challenge stemmed from Louisiana's lawsuit seeking to restrict mifepristone, arguing it undermined the state's ban. Manufacturers of mifepristone had filed emergency appeals, prompting the Supreme Court's intervention. While anti-abortion groups like Students for Life decried the decision, pro-choice providers, who had been preparing to switch to misoprostol-only regimens, welcomed the temporary restoration of access. Justice Alito's order will remain in effect for another week as both sides respond and the court conducts a more thorough review of the matter.
